Sterling Biotech and Zydus Lifesciences agree to extend completion of business transfer
Zydus Lifesciences and SBL have mutually decided to extend the date of closing upto March 31, 2025
Zydus Lifesciences and SBL have mutually decided to extend the date of closing upto March 31, 2025
Octreotide is synthetic peptide manufactured by Shilpa Pharma Lifesciences through solid phase synthesis
This is used to treat central diabetes insipidus and bedwetting
Professor G. D. Yadav is one of India’s most prolific and accomplished engineering-scientists, holding the prestigious National Science Chair from the Government of India
ALS patients experience neuroinflammation and rapid neurodegeneration
The company is also looking at an inorganic opportunity over the next two years to have a commercially ready footprint in the US
Research & Development (R&D) investments for the quarter stood at Rs. 392.5 crore which is 6.3% of its revenues
EBITDA at Rs. 250 crore, up 47% YoY, with 35% EBITDA margin
Ursodeoxycholic acid or ursodiol is a naturally occurring bile acid that is used dissolve cholesterol gall stones
Zydus receives final approval from USFDA for its NDA Zituvimeta, extended-release tablets
Subscribe To Our Newsletter & Stay Updated